We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Temporarily Powers Down OTC Plant After Form 483
Novartis Temporarily Powers Down OTC Plant After Form 483
January 6, 2012
Novartis has temporarily shuttered its Lincoln, Neb., OTC drug plant after being hit with a 13-page Form 483 noting a “pattern of problems” with investigations into foreign tablets in product batches.